Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by digger144on Jul 07, 2011 8:33pm
491 Views
Post# 18808848

Latest Release..

Latest Release..
The most noteworthy was hole GF11-206...24.20 metres @ 3.94 g/t which cut the 147 Zone from 255.57 metres (downhole) to 279.77 metres (downhole).  What I believe is very significant is that at the bottom of the Zone namely, 268.00 metres (downhole) to 279.77 metres (downhole) they hit 11.77 metres @ 6.86 g/t.....this is outstanding!

The mineralization has now been traced to a vertical depth of 240 metres!

The high-grade found in the bottom of hole GF11-206 is telling me that the chances of finding more high-grade further at depth is excellent!  This baby is not slowing down!  Can you believe this...the gold system is maintaining its gold distribution from surface to a vertical depth of 240 metres!

If you like, refer to the Drill Hole Location Plan Map-Black Fox Complex's New Discovery 147 Zone..and locate hole GF11-206.  What I am really excited about...I mentioned this before is the tight formation of holes in close proximity to hole GF11-206 namely,  GF11-204...GF11-227...GF11-223...GF11-216.

I suspected that those holes were drilled in tight formation for a reason and they more than likely hit something significant...well...here is the proof...GF11-206.

I cannot wait for the assay results of the above mentioned holes...it will light up the stock!

For those of you that may not be familar with economical underground mining widths...that hit in hole GF11-206 is not a normal hit...it is most excellent!

Am I excited...you bet I am!

The market will soon recognize the potential of the 147 Zone and reward the share price accordingly to reflect the true value of this find and the part it will play in the future growth potential of Brigus Gold.  It appears to me to have the making of a Company Maker!

Digger144

P.S.  Thus far...the stock is not getting much credit for the 147 Zone...that will change!

Bullboard Posts